CASI Pharmaceuticals Inc.

NASDAQ: CASI · Real-Time Price · USD
2.48
0.54 (27.84%)
At close: Aug 15, 2025, 2:37 PM

CASI Pharmaceuticals Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-1.11 -3.55 -0.62 -2.88
PEG Ratio
-0.04 0.12 -0.16 0.08
PS Ratio
1.52 2.82 0.57 3.61
PB Ratio
23.45 3.96 0.55 1.29
P/FCF Ratio
-1.47 -4.31 -0.91 -2.57
P/OCF Ratio
-1.49 -4.79 -1.16 -4.06
OCF/S Ratio
-1.02 -0.59 -0.49 -0.89
Debt / Equity Ratio
11.96 0.88 0.03 0.03
Quick Ratio
0.94 2.60 3.96 4.56
Current Ratio
1.09 3.55 4.32 4.70
Asset Turnover
0.53 0.45 0.45 0.22
Interest Coverage
-45.49 n/a -427.27 n/a
Return on Equity
-21.21 -1.11 -0.88 -0.45
Return on Assets
-0.73 -0.36 -0.41 -0.27
Return on Invested Capital
-1.12 -0.42 -0.35 -0.29
Dividend Yield
0.02 n/a n/a n/a
Payout Ratio
-0.02 n/a n/a n/a
Gross Profit Margin
0.39 0.59 0.63 0.58
Net Profit Margin
-1.38 -0.8 -0.91 -1.25
Pretax Profit Margin
-1.33 -0.78 -0.87 -1.19
Operating Profit Margin
-1.39 -0.74 -0.61 -1.17
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-1.22 -0.64 -0.56 -1.09